Divya Pathania, Ph.D.
Affiliations: | 2013 | Pharmacy/Pharmaceutical Sciences | University of Southern California, Los Angeles, CA, United States |
Area:
PharmacyGoogle:
"Divya Pathania"Mean distance: (not calculated yet)
Parents
Sign in to add mentor| Nouri Neamati | grad student | 2013 | USC | |
| (Targeting cellular redox modulations for pancreatic cancer treatment.) | ||||
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Huang CH, Park YI, Lin HY, et al. (2019) Compact and Filter-Free Luminescence Biosensor for Mobile Diagnoses. Acs Nano |
| Giedt RJ, Pathania D, Carlson JCT, et al. (2018) Single-cell barcode analysis provides a rapid readout of cellular signaling pathways in clinical specimens. Nature Communications. 9: 4550 |
| Min J, Im H, Allen M, et al. (2018) Computational Optics Enables Breast Cancer Profiling in Point-Of-Care Settings. Acs Nano |
| Giedt RJ, Fumene Feruglio P, Pathania D, et al. (2016) Computational imaging reveals mitochondrial morphology as a biomarker of cancer phenotype and drug response. Scientific Reports. 6: 32985 |
| Pathania D, Im H, Kilcoyne A, et al. (2016) Holographic Assessment of Lymphoma Tissue (HALT) for Global Oncology Field Applications. Theranostics. 6: 1603-10 |
| Sanna V, Nurra S, Pala N, et al. (2016) Targeted Nanoparticles for the Delivery of Novel Bioactive Molecules to Pancreatic Cancer Cells. Journal of Medicinal Chemistry |
| Giedt RJ, Fergulio PF, Pathania D, et al. (2016) Abstract 234: Mitochondrial morphology as a biomarker of cancer phenotype and drug response Cancer Research. 76: 234-234 |
| Pathania D, Kuang Y, Sechi M, et al. (2015) Mechanisms underlying the cytotoxicity of a novel quinazolinedione-based redox modulator, QD232, in pancreatic cancer cells. British Journal of Pharmacology. 172: 50-63 |
| Pathania D, Sechi M, Palomba M, et al. (2014) Design and discovery of novel quinazolinedione-based redox modulators as therapies for pancreatic cancer. Biochimica Et Biophysica Acta. 1840: 332-43 |
| Pathania D, Sechi M, Palomba M, et al. (2013) Abstract 4555: Design and discovery of novel small molecule redox modulators as therapies for pancreatic cancer. Cancer Research. 73: 4555-4555 |